Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Brain Pathology (Zurich, Switzerland)|October 30, 2016
Multiple sclerosis animal models: a clinical and histopathological perspectiveMarkus Kipp, Stella Nyamoya, Tanja Hochstrasser, et al.Journal of Molecular Neuroscience : MN|February 27, 2017
Cuprizone-Containing Pellets Are Less Potent to Induce Consistent Demyelination in the Corpus Callosum of C57BL/6 MiceTanja Hochstrasser, Gianna Lisa Exner, Stella Nyamoya, et al.Cells|November 6, 2019
Laquinimod Supports Remyelination in Non-Supportive EnvironmentsStella Nyamoya, Julia Steinle, Uta Chrzanowski, et al.Brain Research|September 6, 2016
Acute axonal damage in three different murine models of multiple sclerosis: A comparative approachKatharina Marie Höflich, Cordian Beyer, Tim Clarner, et al.Molecular Neurobiology|June 7, 2018
G-Protein-Coupled Receptor Gpr17 Expression in Two Multiple Sclerosis Remyelination ModelsStella Nyamoya, Patrizia Leopold, Birte Becker, et al.Metabolic Brain Disease|September 19, 2019
Nrf2 deficiency increases oligodendrocyte loss, demyelination, neuroinflammation and axonal damage in an MS animal modelAnna Nellessen, Stella Nyamoya, Adib Zendedel, et al.Journal of Molecular Neuroscience : MN|August 25, 2018
Nrf2 Signaling in Sodium Azide-Treated Oligodendrocytes Restores Mitochondrial FunctionsAnnette Liessem-Schmitz, Nico Teske, Miriam Scheld, et al.Journal of Molecular Neuroscience : MN|December 15, 2018
Mitochondrial Impairment in Oligodendroglial Cells Induces Cytokine Expression and SignalingMiriam Scheld, Athanassios Fragoulis, Stella Nyamoya, et al.Journal of Molecular Neuroscience : MN|May 4, 2017
Formyl Peptide Receptor 1-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced DemyelinationKai Bihler, Eugenia Kress, Stefan Esser, et al.Molecular Neurobiology|December 31, 2017
Toll-Like Receptor 2-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced DemyelinationStefan Esser, Larissa Göpfrich, Kai Bihler, et al.Pageof 2